HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Correlation of MUC1 expression to adhesion of breast cancer cell line MDA-MB-231].

AbstractBACKGROUND & OBJECTIVE:
Recent researches found that an abundant production of mucin protein well correlates with tumor cell metastasis. This study was to investigate inhibitory effect of benzyl-alpha-GalNAc on production of mucin 1 (MUC1), and on adhesion and invasion of breast cancer cell line MDA-MB-231.
METHODS:
MDA-MB-231 cells were incubated with benzyl-alpha-GalNAc, expression of MUC1 was detected by immunohistochemistry, adhesive ability of MDA-MB-231 cells to artificial basement membrane Matrigel was measured by MTT assay. Gelatin zymography was performed to detect the secretion changes of matrix metalloproteinase-2 (MMP-2) and MMP-9.
RESULTS:
Compared with control cells, the tumor cells deglycosylated by benzyl-alpha-GalNAc showed lower expression of MUC1 (P < 0.05), and less adhesion to the Matrigel (P< 0.01), the secretion of MMP-2 and MMP-9 suppressed (P< 0.05).
CONCLUSION:
The expression of MUC1 correlates to adhesion and invasion of MDA-MB-231 cells, benzyl-alpha-GalNAc may weaken adhesion and type IV collagenase-secreting activity of MDA-MB-231 cells by inhibiting MUC1.
AuthorsLi Lu, Hua-Yu Deng, Wei-Ke Fan
JournalAi zheng = Aizheng = Chinese journal of cancer (Ai Zheng) Vol. 23 Issue 11 Pg. 1294-6 (Nov 2004) China
PMID15522176 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzyl Compounds
  • Mucin-1
  • benzyl-alpha-N-acetylgalactosamine
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Acetylgalactosamine
Topics
  • Acetylgalactosamine (analogs & derivatives, pharmacology)
  • Benzyl Compounds (pharmacology)
  • Breast Neoplasms (enzymology, metabolism, pathology)
  • Cell Adhesion (drug effects)
  • Cell Line, Tumor
  • Female
  • Humans
  • Matrix Metalloproteinase 2 (metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • Mucin-1 (metabolism)
  • Neoplasm Invasiveness

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: